Cost Transparency Rx

Senate Bill (SB) 17 (Chapter 603, Statutes of 2017)


Download the Current List of
Registered Rx Purchasers

Download the list of registered prescription drug purchasers for the purpose of 60-day advance notice of a specified increase in the wholesale acquisition cost of a prescription drug, as required by Senate Bill 17. This list will be updated weekly or as needed to include all current registrants.

Register for
Rx Purchaser Notifications

Register to receive 60-day advance notice of a specified increase in the wholesale acquisition cost of a prescription drug from prescription drug manufacturers.



Senate Bill (SB) 17 (Chapter 603, Statutes of 2017)

The implementation plan outlined below describes the provisions of SB 17 involving OSHPD. There are also provisions that will be implemented by the Department of Managed Health Care and the California Department of Insurance.

Read Senate Bill 17

Implementation Plan

Beginning January 1, 2018, SB 17 requires OSHPD to make available a registry of public and private purchasers for purposes of the 60-day advance notice requirement for specified increases in the wholesale acquisition cost of a prescription drug. Public and private purchasers may register with OSHPD beginning December 1, 2017 on this website.

Beginning January 1, 2019, drug manufacturers must notify OSHPD within three days of introducing a new drug at a wholesale acquisition cost that exceeds the specified threshold. Within 30 days of this notification, manufacturers must submit additional information to OSHPD. OSHPD will publish this information on its website quarterly.

Beginning after January 1, 2019, drug manufacturers are required to submit to OSHPD information on the rationale for cost increases for existing drugs that fall under the reporting requirement. OSHPD will collect this information beginning April 2019 and publish on its website within 60 days of receipt from each manufacturer on a quarterly basis.

The following implementation plan describes the provisions of SB 17 involving OSHPD.

Projected Time Period
OSHPD Activities
November - December 2017 Compile a registry of state purchasers, healthcare service plans, health insurers, and pharmacy benefit managers that wish to receive 60-day notices of future increases, above the threshold specified, of the wholesale acquisition cost of prescription drugs.
December 1, 2017 Open portal on OSHPD website for purchasers to register to receive 60-day notice.
January 1, 2018 Registry to be available to drug manufacturers on OSHPD website.
January - March 2018 Begin outreach to stakeholders.
April - June 2018 Draft regulations that will take effect January 2019.
September - December 2018 Release information reporting requirements and information collection format to drug manufacturers.
January 2019 Begin collecting information related to new prescription drugs from drug manufacturers. OSHPD to publish this information quarterly on its website beginning Spring 2019.
April 2019 Begin collecting first quarter 2019 prescription drug cost increase information for existing drugs from drug manufacturers.
By June 2019 Publish first quarter 2019 drug cost increase information for existing drugs on OSHPD website.

Download SB 17 Implementation Plan


This page was last updated on Friday, December 29, 2017.

Contact CTRx

Email Cost Transparency Rx Email Cost Transparency Rx

Sign up for CTRx Informational Announcements Sign up for CTRx Informational Announcements